Mild Cognitive Impairment (MCI) clinical trials in North Carolina
18 active Mild Cognitive Impairment (MCI) trials with a site in North Carolina. Describe your situation to see which ones look like a fit.
- Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
- Multi-session Transcranial Alternating Current Stimulation to Improve Dual-task Standing and Brain Activity in Older Adults With Mild Cognitive Impairment
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
- Home Sleep Therapy for Older Adults With MCI
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- ADRC Clinical Cohort (Alzheimer's Disease)
- Wake Forest Alzheimer's Disease Clinical Core
- Retinal Imaging in Neurodegenerative Disease
- Neuromodulation of Memory in Aging
- Cognition, Flavonoids, Exercise, Gut Microbiome
- Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers
- Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
- Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)
- Alzheimer's Disease Neuroimaging Initiative 4
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.